Avivia is an independent Pharmaceutical Contract Research Organization (CRO) based in the Netherlands (EU), specialising in drug formulation, reformulation, repurposing, repositioning, analytical support, and excipient characterisation. Founded in 2015, Avivia offers a unique combination of expertise in formulation and CMC development for generic drugs, lifecycle management of branded products, and new drug entities (NCE). This comprehensive service suite enables Avivia to effectively bridge the gap between Active Pharmaceutical Ingredient (API) development and final product manufacturing.

Services include:
– Formulation Development
– Excipient Characterization
– Dissolution Testing
– Analysis & Analytical Method Development

Avivia is committed to optimising the development process for clients in the pharmaceutical industry, ensuring efficiency and reducing risk. For more information, please visit avivia.nl.